EUVIMEDEUVIMED entdecken
Open Access

Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial

Francisco O Cortés-Ibáñez, Theron Johnson, Mario Mascalchi, Verena Katzke, Stefan Delorme, Rudolf Kaaks

Translational Lung Cancer Research · 2023-12 · 12 (12) · 2460-2475

DOI: 10.21037/tlcr-23-548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2023-12. Verfasst von Francisco O Cortés-Ibáñez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology (C020), German Cancer Research Center (DKFZ), Heidelberg, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Serum biomarkerslung cancer screening (LC screening)lung function impairment (spirometry)mortalityrisk modeling

Autor:innen und Institutionen

  • Division of Cancer Epidemiology (C020), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Translational Lung Research Center Heidelberg (TLRC-H), the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Division of Epidemiology and Clinical Governance, Institute for Study, Prevention and Network in Oncology (ISPRO), Florence, Italy.
  • Department of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Zitieren

APA

Cortés-Ibáñez, F. O., Johnson, T., Mascalchi, M., Katzke, V., Delorme, S., & Kaaks, R. (2023). Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial. Translational Lung Cancer Research, 12(12), 2460-2475. https://doi.org/10.21037/tlcr-23-548

Vancouver

Cortés-Ibáñez FO, Johnson T, Mascalchi M, Katzke V, Delorme S, Kaaks R. Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial. Translational Lung Cancer Research. 2023;12(12):2460-2475. doi:10.21037/tlcr-23-548

BibTeX
@article{CortsIbez2023,
  author = {Cortés-Ibáñez, Francisco O and Johnson, Theron and Mascalchi, Mario and Katzke, Verena and Delorme, Stefan and Kaaks, Rudolf},
  title = {Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial},
  journal = {Translational Lung Cancer Research},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {2460--2475},
  doi = {10.21037/tlcr-23-548}
}
Kostenlos starten →